RSPO3-LGR4-maintained Wnt signaling is essential for the stemness of acute myeloid leukemia, and the clinical-grade anti-RSPO3 antibody eradicated leukemia stem cells [149], which might be effective in GI cancer. Here, RSPO3 is linked to leukemia.